Exploring the potential mechanism of WuFuYin against hypertrophic scar using network pharmacology and molecular docking

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

242

Figures (1-6)

Tables (1-1)

Sum=325

Publishing Process of This Article

Item

Count

Browse

Download

Sum=3

Jun 26, 2024 (publication date) through Jun 29, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Clin Cases. Jun 26, 2024; 12(18): 3505-3514
Published online Jun 26, 2024. doi: 10.12998/wjcc.v12.i18.3505

Table 1 Molecular docking results of the target proteins and active compounds

Targets	Mol ID	Molecule name	Docking score (kcal/mol)
CDK2	MOL004941	(2R)-7-hydroxy-2-(4-hydroxyphenyl) chroman-4-one	-2.89
GSK3B	MOL004989	6-prenylated eriodictyol	-1.62
GSK3B	MOL004993	8-prenylated eriodictyol	-3.12

Citation: Zhang SY, Guo SX, Chen LL, Zhu JY, Hou MS, Lu JK, Shen XX. Exploring the potential mechanism of WuFuYin against hypertrophic scar using network pharmacology and molecular docking. World J Clin Cases 2024; 12(18): 3505-3514
URL: https://www.wjgnet.com/2307-8960/full/v12/i18/3505.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i18.3505